Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 [Phase 4]
This report covers a completed Phase 4 trial and its 24-week open-label extension evaluating the rivastigmine transdermal patch in patients …
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease [Phase 3]
Phase 3 trial update for Dimebon in mild-to-moderate Alzheimer's disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 trial comparing 23 mg sustained-release donepezil to 10 mg immediate-release donepezil in moderate-to-severe Alzheimer's disease; re…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]
Phase 2 study evaluating efficacy and safety in subjects with mild-to-moderate Alzheimer's disease has completed; the document provides an u…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease [Phase 2]
A Phase 2 trial comparing three dosage levels of SAM-531 in outpatients with mild-to-moderate Alzheimer disease was terminated, with results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden [Phase 2]
Phase 2 study sponsored by AstraZeneca compares PET measurements of fibrillar amyloid burden in Alzheimer's disease. The trial status is com…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]
A completed Phase 2 trial evaluated ABT-384 for efficacy and safety in patients with mild-to-moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease
This clinical trial update reports the completion of a study evaluating different treatment care methods for dementia associated with Alzhei…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers [Phase 1]
Phase 1 study evaluating BAY1006578 for diagnostic potential in probable Alzheimer's disease and assessing radiation dosimetry in healthy vo…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease [Phase 2]
Phase 2 trial of rosiglitazone extended-release for Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: iCare Stress Management e-Training for Dementia Family Caregivers [Phase 2]
Phase 2 results for iCare Stress Management e-Training designed for dementia family caregivers have been posted.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Efficacy and Safety of Filgrastim in Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating the efficacy and safety of filgrastim in Alzheimer's disease. Results were posted in December 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial assessed the efficacy of galantamine in improving attention in patients with Alzheimer's disease, with results post…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days [Phase 2]
A Phase 2 trial evaluating nasal insulin detemir to address forgetfulness in Alzheimer's disease and mild cognitive impairment has completed…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: A Study of V950 in People With Alzheimer Disease (V950-001 AM7) [Phase 1]
Phase 1 results from a Merck-sponsored study of V950 in people with Alzheimer's disease; the trial has completed and results were posted in …
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy [NA]
A completed clinical trial update describing an ecological assessment of apathy in Alzheimer's disease and in control subjects using video r…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients [NA]
A completed clinical trial assessed the effects of direct current stimulation on cognitive function in mild-to-moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Effect of LY2062430 on the Progression of Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating LY2062430 for progression in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease [Phase 1]
A completed Phase 1 PET study evaluating how varying masses of AZD4694 affect radioligand binding in healthy volunteers and patients with Al…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease. [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of lornoxicam in mild to moderate probable Alzheimer’s disease was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Randomized Trial of a Nutritional Supplement in Alzheimer's Disease [Phase 3]
This Clinical Trial Update reports completion of a Phase 3 randomized trial evaluating a nutritional supplement in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease [Phase 3]
Pfizer conducted an extension to a Phase 3 protocol to evaluate the long-term safety and tolerability of dimebon (latrepirdine) in Alzheimer…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients [Phase 1]
A Phase 1 trial assessing the effect of JNJ-39393406 on event-related potentials in stable schizophrenia patients was terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Trazodone for Sleep Disorders in Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating trazodone for sleep disorders in Alzheimer's disease has completed. The document does not report the trial result…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease [Phase 2]
This clinical trial update notes completion of a Phase 2 study evaluating how the delivery mode of a cognition intervention affects outcomes…